超声检查诊断卵巢良恶性肿瘤的临床价值分析

Clinical value of ultrasonography in the diagnosis of benign and malignant ovarian tumors

目的探究超声检查诊断卵巢良恶性肿瘤的临床价值。方法选取2013年3月至2016年3月间琼中黎族苗族自治县人民医院收治的90例卵巢肿瘤患者,按照检测方法不同分为观察组与对照组,每组45例。观察组采用超声检查,对照组采用X线检查,结合病理检查对照,观察分析两组患者卵巢肿瘤良恶性诊断符合率和良恶性病变类型。结果观察组患者超声检测出恶性肿瘤患者23例,符合率为100.0%(23/23),良性肿瘤患者22例,符合率为95.5%(21/22)。观察组中良性肿瘤病理诊断病变类型有卵巢囊肿4例,浆液性囊肿腺瘤3例,黏液性囊肿腺瘤2例,输卵管炎症3例,闭锁黄体3例,红体1例,黄体囊肿2例,副输卵管囊肿2例,子宫内膜异位症1例;恶性肿瘤病理诊断病变类型有腺癌2例,卵巢癌6例,透明细胞癌3例,子宫内膜样癌2例,成熟囊性畸胎瘤3例,乳头状癌2例,梭形细胞肿瘤3例,浆液性囊腺癌2例。对照组患者X线片检测出的恶性肿瘤符合率为80.0%(16/20),良性肿瘤符合率为76.0%(19/25),其良恶性肿瘤的病变类型未有明确辨别,两组患者的良恶性诊断符合率和病变类型差异均有统计学意义(均P<0.05)。结论采用超声检查对卵巢肿瘤患者进行诊断,可较好地提高卵巢肿瘤患者的诊断符合率,对临床诊断和治疗具有较大意义。

Objective To explore the clinical value of uhrasonography in the diagnosis of benign and malignant ovarian tumors. Methods From March 2013 to March 2016, 90 patients with ovarian cancer treated at Qiongzhong Li and Miao Autonomous County People＇s Hospital were selected as the research sub- ject. According to the detection method, patients were divided into an observation group and a control group with 45 patients in each group. Ultrasonography was performed on the observation group and X-ray was per- formed on the control group. Diagnostic coincidence rate and lesion type were compared between the two groups. Results In the observation, malignant tumors were detected in 23 patients and the coincidence rate was 100. 0% （23/23） , and benign tumors were detected in 22 patients and the coincidence rate was 95.5% （21/22）. For the benign tumors, pathologic diagnosis revealed lesion type included oophorocystis in 4 patients, serous cyst adenoma in 3 patients, mucinous cyst adenoma in 2 patients, salpingitis in 3 pa- tients, atretic corpus luteum in 3 patients, corpora haemorrhagicum in l patient, luteal cysts in 2 patients,accessory tubal cyst in 2 patients and endometriosis in 1 patient. For malignant lesion type, adenocarcinoma was detected in 2 patients, ovarian cancer in 6 patients, clear cell carcinoma in 3 patients, endometrioid carcinoma in 2 patients, mature cystic teratoma in 3 patients, papillary carcinoma in 2 patients, spindle cell tumor in 3 patients and serous cystadenocarcinoma in 2 patients. For the control group, diagnostic coinci- dence rate was 80.0% （16/20） for the malignant tumors and 76.0% （19/25） for the benign tumors. There was no clear distinction between benign and malignant leisions. Statistically significant differences were noted in diagnostic coincidence rate and leision tyoes between the two groups （ P 〈 0. 05 ）. Conclusion The use of ultrasound in the diagnosis of ovarian cancer can improve the diagnostic coincidence rate and is of great importance for clinical diagnosis and treatment.